Kynam Capital Management, LP has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $1.19 Billion distributed in 32 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Natera, Inc. with a value of $165M, Vaxcyte, Inc. with a value of $121M, Celldex Therapeutics, Inc. with a value of $118M, Amarin Corp Plcuk with a value of $111M, and Syndax Pharmaceuticals Inc with a value of $105M.
Examining the 13F form we can see an decrease of $392M in the current position value, from $1.58B to 1.19B.
Kynam Capital Management, LP is based out at Princeton, NJ
Below you can find more details about Kynam Capital Management, LP portfolio as well as his latest detailed transactions.